{"id":7394,"date":"2026-04-24T12:41:52","date_gmt":"2026-04-24T04:41:52","guid":{"rendered":"https:\/\/witology.com.tw\/daily-biohealth\/2026-04-24\/"},"modified":"2026-04-24T12:41:52","modified_gmt":"2026-04-24T04:41:52","slug":"9-46","status":"publish","type":"page","link":"https:\/\/witology.com.tw\/en\/daily-biohealth\/9-46\/","title":{"rendered":"Biomedical Health Industry Daily 2026-04-24\uff5cPfizer halts work on next-gen drug combinations in cancer patients"},"content":{"rendered":"\n<style>.wit-daily {\n  --bg:#0f0e0c;--bg2:#16140f;--fg:#e8e3d8;--dim:#8a8276;--mute:#5a5448;\n  --card:#1a1816;--card2:#221f1b;--bdr:#3a342e;--bdr2:#4a423a;\n  --acc:#c4b09a;--acc2:#d4a574;--acc3:#7a6e62;\n  --tw:#e07a6a;--us:#7ab3d4;\n  --up:#8fc78a;--dn:#d97070;--nu:#9a9282;\n  --warn:#d4a574;\n  --line-h:1.85;\n}\n.wit-daily * {margin:0;padding:0;box-sizing:border-box}\n.wit-daily {background:var(--bg)}\n.wit-daily {font-family:\"Noto Sans TC\",sans-serif;background:var(--bg);color:var(--fg);line-height:var(--line-h);-webkit-font-smoothing:antialiased;background-image:radial-gradient(ellipse 80% 40% at 50% 0%,rgba(196,176,154,.06),transparent 70%)}\n.wit-daily .wrap {max-width:860px;margin:0 auto;padding:40px 22px 80px}\n.wit-daily .hdr {text-align:center;padding:64px 0 48px;margin-bottom:48px;border-bottom:1px solid var(--bdr)}\n.wit-daily .hdr-date {font-size:12px;letter-spacing:8px;color:var(--acc);text-transform:uppercase;margin-bottom:14px;font-weight:500}\n.wit-daily .hdr h1 {font-family:\"Noto Serif TC\",serif;font-size:clamp(30px,5vw,46px);font-weight:700;letter-spacing:3px;margin-bottom:12px;background:linear-gradient(135deg,var(--fg) 0%,var(--acc) 100%);-webkit-background-clip:text;-webkit-text-fill-color:transparent;background-clip:text}\n.wit-daily .hdr-sub {font-size:13px;color:var(--dim);letter-spacing:1px}\n.wit-daily .stats {margin-bottom:48px}\n.wit-daily .st {display:flex;align-items:center;gap:12px;margin-bottom:8px}\n.wit-daily .st-bar {height:3px;border-radius:2px;min-width:3px;transition:width .5s;opacity:.85}\n.wit-daily .st-lb {font-size:13px;flex:1;color:var(--fg)}\n.wit-daily .st-ct {font-size:12px;color:var(--dim);min-width:24px;text-align:right;font-variant-numeric:tabular-nums}\n.wit-daily .lbl {font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;color:var(--fg);margin-bottom:28px;padding-bottom:12px;border-bottom:2px solid var(--acc);letter-spacing:1px}\n.wit-daily .c {background:var(--card);border:1px solid var(--bdr);border-radius:4px;margin-bottom:36px;overflow:hidden;box-shadow:0 4px 24px rgba(0,0,0,.35),0 1px 0 rgba(196,176,154,.05) inset;backdrop-filter:blur(16px)}\n.wit-daily .c-hd {display:flex;justify-content:space-between;align-items:center;padding:22px 30px 0}\n.wit-daily .c-cat {font-size:10px;font-weight:700;letter-spacing:3px;text-transform:uppercase;color:var(--cc,var(--acc));border:1px solid var(--cc,var(--acc));padding:3px 12px;border-radius:2px;background:rgba(0,0,0,.2)}\n.wit-daily .c-snt {font-size:13px;font-weight:600;letter-spacing:.5px}\n.wit-daily .s-up {color:var(--up)}\n.wit-daily .s-dn {color:var(--dn)}\n.wit-daily .s-nu {color:var(--nu)}\n.wit-daily .c-t {padding:14px 30px 4px;font-family:\"Noto Serif TC\",serif;font-size:24px;font-weight:700;line-height:1.45;letter-spacing:.5px}\n.wit-daily .c-t a {color:var(--fg);text-decoration:none;transition:color .25s}\n.wit-daily .c-t a:hover {color:var(--acc2)}\n.wit-daily .c-src {padding:0 30px 14px;font-size:12px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .c-hype {display:flex;align-items:center;gap:14px;padding:10px 30px 14px;border-top:1px dashed var(--bdr);border-bottom:1px dashed var(--bdr);background:rgba(196,176,154,.03)}\n.wit-daily .c-hype-lb {font-size:10px;letter-spacing:2px;text-transform:uppercase;color:var(--dim);font-weight:700}\n.wit-daily .c-hype-dots {font-size:14px;color:var(--acc2);letter-spacing:3px;font-family:monospace}\n.wit-daily .c-hype-tx {font-size:12px;color:var(--acc);font-weight:500}\n.wit-daily .c-stocks {padding:14px 30px 18px;display:flex;flex-wrap:wrap;gap:6px}\n.wit-daily .stk {display:inline-flex;align-items:center;gap:4px;font-size:12px;padding:4px 12px;border-radius:2px;font-weight:500}\n.wit-daily .stk b {font-weight:700}\n.wit-daily .stk-tw {background:rgba(224,122,106,.12);color:var(--tw);border:1px solid rgba(224,122,106,.35)}\n.wit-daily .stk-us {background:rgba(122,179,212,.12);color:var(--us);border:1px solid rgba(122,179,212,.35)}\n.wit-daily .stk-other {background:rgba(255,255,255,.04);color:var(--dim);border:1px solid var(--bdr2)}\n.wit-daily .chg {font-size:11px;font-weight:600;padding:1px 6px;border-radius:2px;margin-left:2px}\n.wit-daily .chg-up {background:rgba(226,100,80,.20);color:#ff8f78}\n.wit-daily .chg-down {background:rgba(94,181,141,.20);color:#7ed0a6}\n.wit-daily .chg-flat {background:rgba(255,255,255,.06);color:var(--dim)}\n.wit-daily .c-img {width:100%;height:auto;aspect-ratio:1170\/540;object-fit:cover;border-top:1px solid var(--bdr);border-bottom:1px solid var(--bdr);filter:brightness(.92);display:block}\n.wit-daily .c-analysis {display:grid;grid-template-columns:1fr 1fr;border-top:1px solid var(--bdr)}\n.wit-daily .c-sec {padding:22px 30px;border-bottom:1px solid var(--bdr)}\n.wit-daily .c-sec:nth-child(odd) {border-right:1px solid var(--bdr)}\n.wit-daily .c-wide {grid-column:1\/-1;border-right:none !important}\n.wit-daily .c-sec h4 {font-size:14px;letter-spacing:2px;text-transform:uppercase;color:var(--acc);margin-bottom:12px;font-weight:700}\n.wit-daily .c-sec p {font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92}\n.wit-daily .c-counter {background:rgba(212,165,116,.05)}\n.wit-daily .c-counter h4 {color:var(--warn)}\n.wit-daily .c-counter blockquote {border-left:3px solid var(--warn);padding:6px 0 6px 16px;font-size:14px;line-height:var(--line-h);color:var(--fg);opacity:.92;font-style:italic;margin:0}\n.wit-daily .c-watch {background:rgba(196,176,154,.04)}\n.wit-daily .c-watch-grid {display:grid;grid-template-columns:1fr 1fr 1fr;gap:18px;margin-top:6px}\n.wit-daily .c-watch-col {}\n.wit-daily .c-watch-h {font-size:12px;font-weight:700;color:var(--fg);margin-bottom:10px;padding-bottom:6px;border-bottom:1px solid var(--bdr2);display:flex;flex-direction:column;gap:2px}\n.wit-daily .c-watch-h span {font-size:10px;color:var(--dim);letter-spacing:1px;font-weight:400}\n.wit-daily .c-w-short {border-bottom-color:var(--dn)}\n.wit-daily .c-w-mid {border-bottom-color:var(--acc2)}\n.wit-daily .c-w-long {border-bottom-color:var(--up)}\n.wit-daily .c-watch-col ul {list-style:none;padding:0;margin:0}\n.wit-daily .c-watch-col li {font-size:13px;line-height:1.7;color:var(--fg);opacity:.88;padding:6px 0 6px 16px;position:relative}\n.wit-daily .c-watch-col li:before {content:\"\u25b8\";position:absolute;left:0;color:var(--acc);font-size:12px}\n.wit-daily .c-faqs {background:rgba(122,179,212,.04)}\n.wit-daily .c-faqs h4 {color:var(--us)}\n.wit-daily .c-faq-item {border-bottom:1px solid var(--bdr);padding:10px 0}\n.wit-daily .c-faq-item:last-child {border-bottom:none}\n.wit-daily .c-faq-item summary {cursor:pointer;font-size:14px;font-weight:600;color:var(--fg);padding:6px 0;list-style:none;display:flex;align-items:center;gap:10px;transition:color .2s}\n.wit-daily .c-faq-item summary::before {content:\"+\";color:var(--us);font-weight:700;font-size:18px;width:14px;display:inline-block;transition:transform .2s}\n.wit-daily .c-faq-item[open] summary::before {content:\"\u2212\"}\n.wit-daily .c-faq-item summary:hover {color:var(--acc2)}\n.wit-daily .c-faq-item p {font-size:13px;line-height:1.8;color:var(--fg);opacity:.85;padding:8px 0 6px 24px;margin:0}\n.wit-daily .c-ft {padding:16px 30px;border-top:1px solid var(--bdr);text-align:right;background:rgba(0,0,0,.15)}\n.wit-daily .c-ft a {font-size:13px;color:var(--acc);text-decoration:none;font-weight:500;transition:color .25s;letter-spacing:.5px}\n.wit-daily .c-ft a:hover {color:var(--acc2)}\n.wit-daily .briefs {background:var(--card);border:1px solid var(--bdr);border-radius:4px;padding:8px 0;margin-bottom:48px;box-shadow:0 2px 12px rgba(0,0,0,.25)}\n.wit-daily .b-item {display:flex;gap:12px;padding:12px 26px;border-bottom:1px solid var(--bdr);align-items:flex-start}\n.wit-daily .b-item:last-child {border-bottom:none}\n.wit-daily .b-dot {width:7px;height:7px;border-radius:50%;margin-top:9px;flex-shrink:0;box-shadow:0 0 8px currentColor}\n.wit-daily .b-link {color:var(--fg);text-decoration:none;font-size:14px;transition:color .25s;display:block;margin-bottom:2px;line-height:1.6}\n.wit-daily .b-link:hover {color:var(--acc2)}\n.wit-daily .b-meta {font-size:11px;color:var(--dim);letter-spacing:.5px}\n.wit-daily .ftr {text-align:center;padding:36px 0;font-size:11px;color:var(--mute);border-top:1px solid var(--bdr);margin-top:24px;letter-spacing:1px}\n@media(max-width:680px) {.wit-daily .c-analysis {grid-template-columns:1fr}\n.wit-daily .c-sec:nth-child(odd) {border-right:none}\n.wit-daily .c-wide {grid-column:1}\n.wit-daily .c-t {font-size:19px;padding:12px 20px 4px}\n.wit-daily .c-hd, .wit-daily .c-src, .wit-daily .c-stocks, .wit-daily .c-sec, .wit-daily .c-ft, .wit-daily .c-hype {padding-left:20px;padding-right:20px}\n.wit-daily .c-watch-grid {grid-template-columns:1fr;gap:14px}}\n\/* \u5168\u57df(\u975e scoped):\u50c5\u8a72\u7522\u696d\u65e5\u5831\u5b50\u9801\u751f\u6548 *\/\nbody.parent-pageid-7356 .fusion-page-title-bar,\nbody.parent-pageid-7356 .fusion-page-title-row,\nbody.parent-pageid-7356 .fusion-page-title-wrapper {\n  display: none !important;\n  height: 0 !important;\n  padding: 0 !important;\n  margin: 0 !important;\n}\nbody.parent-pageid-7356 #main,\nbody.parent-pageid-7356 #content,\nbody.parent-pageid-7356 .fusion-row,\nbody.parent-pageid-7356 .post-content,\nbody.parent-pageid-7356 article.post {\n  padding-top: 0 !important;\n  margin-top: 0 !important;\n}\n\n\/* scoped(.wit-daily) *\/\n.wit-daily {\n  margin-left: calc((100% - 100vw) \/ 2);\n  margin-right: calc((100% - 100vw) \/ 2);\n  padding-left: calc((100vw - 100%) \/ 2);\n  padding-right: calc((100vw - 100%) \/ 2);\n  padding-top: 40px;\n  padding-bottom: 60px;\n  background: #0f0e0c;\n  color: #e8e3d8;\n  font-family: \"Noto Sans TC\", sans-serif;\n}\n.wit-daily .wrap { padding-left: 22px; padding-right: 22px; padding-top: 0; }\n.wit-daily a { color: inherit; }\n\/* \u5f37\u5236\u8986\u84cb Avada \u4e3b\u984c\u53ef\u80fd\u6ce8\u5165\u7684 blockquote \u767d\u5e95 *\/\n.wit-daily .c-counter blockquote,\n.wit-daily blockquote {\n  background: transparent !important;\n  background-color: transparent !important;\n  color: #e8e3d8 !important;\n  border-left: 3px solid #d4a574 !important;\n  padding: 6px 0 6px 16px !important;\n  font-style: italic !important;\n  margin: 0 !important;\n  box-shadow: none !important;\n}\n.wit-daily .c-counter blockquote::before,\n.wit-daily blockquote::before,\n.wit-daily blockquote::after { content: none !important; }\n<\/style>\n<div class=\"wit-daily\">\n\n<main class=\"wrap\">\n<header class=\"hdr\">\n<div class=\"hdr-date\"><time datetime=\"2026-04-24\">2026 \u5e74 04 \u6708 24 \u65e5<\/time><\/div>\n<h1>\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831<\/h1>\n<p class=\"hdr-sub\">\u5171\u6536\u9304 4 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 3 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/p>\n<\/header>\n<section aria-labelledby=\"sec-featured\">\n<h2 class=\"lbl\" id=\"sec-featured\">\u7cbe\u9078\u6df1\u5ea6\u5206\u6790<\/h2>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#4472C4\">\u85e5\u7269<\/span>\n<span class=\"c-snt s-dn\">\u25bc \u504f\u7a7a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/pfizer-ends-work-phase-1-stage-immunostimulatory-drug-conjugate-cancer-patients\" rel=\"noopener nofollow\" target=\"_blank\">Pfizer\u505c\u6b62\u5728\u764c\u75c7\u60a3\u8005\u4e2d\u7684\u6b21\u4e16\u4ee3\u85e5\u7269\u7d50\u5408\u9ad4\u5de5\u4f5c<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-04-24\" itemprop=\"datePublished\">2026-04-24<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cb\u25cb\u25cb<\/span><span class=\"c-hype-tx\">2\/5 \u00b7 \u6b21\u8981\u52d5\u614b<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>PFE<\/b> Pfizer <span class=\"chg chg-down\">\u25bc0.49% $26.67<\/span><\/span><span class=\"stk stk-other\"><b>RHHBY<\/b> Roche <span class=\"chg chg-flat\">\u2014<\/span><\/span><span class=\"stk stk-us\"><b>AZN<\/b> AstraZeneca <span class=\"chg chg-down\">\u25bc1.29% $192.3<\/span><\/span><span class=\"stk stk-us\"><b>GILD<\/b> Gilead Sciences <span class=\"chg chg-up\">\u25b20.56% $133.64<\/span><\/span><span class=\"stk stk-tw\"><b>6446<\/b> \u85e5\u83ef\u85e5 <span class=\"chg chg-down\">\u25bc1.27% $621.0<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>Pfizer\u7d42\u6b62\u4e86\u4e00\u9805\u8655\u65bcPhase I\u968e\u6bb5\u7684\u514d\u75ab\u523a\u6fc0\u85e5\u7269\u7d50\u5408\u9ad4(immunostimulatory drug conjugate)\u764c\u75c7\u6cbb\u7642\u8a08\u756b\u3002\u6b64\u6c7a\u5b9a\u53cd\u6620\u8a72\u85e5\u7269\u5728\u65e9\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\u672a\u9054\u9810\u671f\u6548\u679c\u6216\u5b89\u5168\u6027\u8003\u91cf,\u986f\u793aADC\u6280\u8853\u8def\u7dda\u4ecd\u5b58\u5728\u958b\u767c\u98a8\u96aa\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u5168\u7403ADC\u5e02\u5834\u9810\u4f302030\u5e74\u5c07\u9054300\u5104\u7f8e\u5143,\u76ee\u524d\u5df2\u6709\u8d85\u904e15\u6b3eADC\u85e5\u7269\u7372\u5f97FDA\u6279\u51c6,\u5305\u62ecKadcyla\u3001Enhertu\u7b49\u91cd\u78c5\u7522\u54c1\u3002Pfizer\u5728ADC\u9818\u57df\u7684\u6295\u8cc7\u8d85\u904e100\u5104\u7f8e\u5143,\u4e3b\u8981\u900f\u904e\u6536\u8cfcSeagen\u5f37\u5316\u7ba1\u7dda\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>\u5927\u578b\u85e5\u5ee0\u5728ADC\u9818\u57df\u7684\u9ad8\u5931\u8d25\u7387\u51f8\u986f\u7cbe\u6e96\u816b\u7624\u5b78\u4ecd\u9762\u81e8\u6280\u8853\u74f6\u9838,\u5373\u4f7f\u662f\u8cc7\u6e90\u8c50\u5bcc\u7684Pfizer\u4e5f\u96e3\u4ee5\u78ba\u4fdd\u6210\u529f\u3002\u6b64\u4e8b\u4ef6\u63d0\u9192\u6295\u8cc7\u4ebaADC\u96d6\u662f\u7576\u524d\u6700\u71b1\u9580\u7684\u764c\u75c7\u6cbb\u7642\u5e73\u53f0\u4e4b\u4e00,\u4f46\u5f9e\u65e9\u671f\u7814\u767c\u5230\u5546\u696d\u5316\u7684\u6210\u529f\u6a5f\u7387\u4f9d\u7136\u504f\u4f4e\u3002\u5c0d\u4e9e\u6d32ADC\u958b\u767c\u5546\u800c\u8a00,\u9019\u4e5f\u610f\u5473\u8457\u6280\u8853\u9580\u6abb\u548c\u7af6\u722d\u98a8\u96aa\u4ecd\u76f8\u7576\u56b4\u5cfb,\u9700\u66f4\u8b39\u614e\u8a55\u4f30\u7ba1\u7dda\u54c1\u8cea\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u55ae\u4e00\u7ba1\u7dda\u505c\u6b62\u53ef\u80fd\u662fPfizer\u7b56\u7565\u6027\u8cc7\u6e90\u91cd\u65b0\u914d\u7f6e,\u5c08\u6ce8\u65bc\u66f4\u6709\u6f5b\u529b\u7684ADC\u9805\u76ee;\u4e14\u514d\u75ab\u523a\u6fc0\u7d50\u5408\u9ad4\u4ecd\u5c6c\u5be6\u9a57\u6027\u6280\u8853,\u5931\u6557\u4e0d\u4ee3\u8868\u6574\u500bADC\u5e02\u5834\u524d\u666f\u53d7\u5f71\u97ff\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>Pfizer Q1\u8ca1\u5831\u662f\u5426\u8abf\u964dADC\u7ba1\u7dda\u9810\u671f<\/li><li>\u5176\u4ed6\u5927\u578b\u85e5\u5ee0ADC\u7ba1\u7dda\u9032\u5c55\u516c\u5e03<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>Seagen\u4f75\u8cfc\u6574\u5408\u6548\u76ca\u662f\u5426\u5982\u671f\u986f\u73fe<\/li><li>\u7af6\u722d\u5c0d\u624bADC\u7522\u54c1\u5e02\u5834\u8868\u73fe<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>\u6b21\u4e16\u4ee3ADC\u6280\u8853\u5e73\u53f0\u6210\u719f\u5ea6<\/li><li>\u4e9e\u6d32ADC\u958b\u767c\u5546\u570b\u969b\u5408\u4f5c\u6a5f\u6703<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>Pfizer\u505c\u6b62\u9019\u9805\u764c\u75c7\u85e5\u7269\u958b\u767c\u5c0d\u516c\u53f8\u5f71\u97ff\u591a\u5927?<\/summary><p>\u5f71\u97ff\u76f8\u5c0d\u6709\u9650,\u56e0\u70baPfizer\u900f\u904e\u6536\u8cfcSeagen\u5df2\u64c1\u6709\u591a\u9805ADC\u7ba1\u7dda,\u55ae\u4e00\u9805\u76ee\u505c\u6b62\u5c6c\u65bc\u6b63\u5e38\u7684\u7814\u767c\u98a8\u96aa\u7ba1\u63a7\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u4ec0\u9ebc\u662f\u514d\u75ab\u523a\u6fc0\u85e5\u7269\u7d50\u5408\u9ad4?<\/summary><p>\u9019\u662f\u7d50\u5408\u6297\u9ad4\u5c0e\u5411\u6027\u8207\u514d\u75ab\u523a\u6fc0\u5291\u7684\u65b0\u578bADC\u6280\u8853,\u65e8\u5728\u7cbe\u6e96\u6295\u905e\u514d\u75ab\u6fc0\u6d3b\u5206\u5b50\u5230\u816b\u7624\u7d30\u80de,\u4f46\u6280\u8853\u8907\u96dc\u5ea6\u6bd4\u50b3\u7d71ADC\u66f4\u9ad8\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>ADC\u85e5\u7269\u958b\u767c\u70ba\u4ec0\u9ebc\u9019\u9ebc\u56f0\u96e3?<\/summary><p>ADC\u9700\u8981\u540c\u6642\u512a\u5316\u6297\u9ad4\u9078\u64c7\u6027\u3001\u9023\u63a5\u5b50\u7a69\u5b9a\u6027\u3001\u6709\u6548\u8f09\u8377\u6bd2\u6027\u7b49\u591a\u500b\u8b8a\u6578,\u4efb\u4e00\u74b0\u7bc0\u5931\u8861\u90fd\u53ef\u80fd\u5c0e\u81f4\u7642\u6548\u4e0d\u8db3\u6216\u6bd2\u6027\u904e\u9ad8\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/biotech\/pfizer-ends-work-phase-1-stage-immunostimulatory-drug-conjugate-cancer-patients\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#4472C4\">\u85e5\u7269<\/span>\n<span class=\"c-snt s-nu\">\u25ac \u4e2d\u6027<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/pharma\/roche-pharma-ceo-maintains-oral-serd-could-be-largest-product-company-history-despite-data\" rel=\"noopener nofollow\" target=\"_blank\">\u5118\u7ba1\u6578\u64da\u5b58\u7591,Roche\u9ad8\u5c64\u5805\u6301\u53e3\u670dSERD\u4ecd\u53ef\u80fd\u6210\u70ba\u516c\u53f8\u53f2\u4e0a\u6700\u5927\u7522\u54c1<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-04-24\" itemprop=\"datePublished\">2026-04-24<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cb\u25cb<\/span><span class=\"c-hype-tx\">3\/5 \u00b7 \u503c\u5f97\u95dc\u6ce8<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-other\"><b>RHHBY<\/b> Roche <span class=\"chg chg-flat\">\u2014<\/span><\/span><span class=\"stk stk-us\"><b>AZN<\/b> AstraZeneca <span class=\"chg chg-down\">\u25bc1.29% $192.3<\/span><\/span><span class=\"stk stk-us\"><b>LLY<\/b> Eli Lilly <span class=\"chg chg-down\">\u25bc0.42% $917.65<\/span><\/span><span class=\"stk stk-us\"><b>PFE<\/b> Pfizer <span class=\"chg chg-down\">\u25bc0.49% $26.67<\/span><\/span><span class=\"stk stk-tw\"><b>4128<\/b> \u4e2d\u5929\u751f\u6280 <span class=\"chg chg-flat\">\u2014<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>Roche\u9ad8\u5c64\u5728\u9762\u81e8\u53e3\u670d\u9078\u64c7\u6027\u96cc\u6fc0\u7d20\u53d7\u9ad4\u964d\u89e3\u5291(SERD)\u81e8\u5e8a\u6578\u64da\u8cea\u7591\u8072\u6d6a\u4e0b,\u4ecd\u5805\u6301\u8a8d\u70ba\u8a72\u7522\u54c1\u5177\u5099\u6210\u70ba\u516c\u53f8\u53f2\u4e0a\u6700\u5927\u7522\u54c1\u7684\u6f5b\u529b\u3002\u6b64\u8868\u614b\u986f\u793aRoche\u5c0d\u4e73\u764c\u6cbb\u7642\u5e02\u5834\u7684\u9577\u671f\u4fe1\u5fc3,\u4f46\u4e5f\u53cd\u6620\u7576\u524d\u6578\u64da\u53ef\u80fd\u672a\u5b8c\u5168\u7b26\u5408\u5e02\u5834\u9810\u671f\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u5168\u7403\u4e73\u764c\u6cbb\u7642\u5e02\u5834\u898f\u6a21\u7d04200\u5104\u7f8e\u5143,\u5176\u4e2d\u8377\u723e\u8499\u53d7\u9ad4\u967d\u6027\u4e73\u764c\u4f5470%\u3002Roche\u76ee\u524d\u6700\u5927\u55ae\u4e00\u7522\u54c1\u70baHerceptin\u7cfb\u5217,\u5e74\u92b7\u552e\u984d\u7d0460\u5104\u7f8e\u5143\u3002\u53e3\u670dSERD\u5e02\u5834\u6f5b\u529b\u9810\u4f30\u53ef\u9054150\u5104\u7f8e\u5143\u4ee5\u4e0a\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>\u53e3\u670dSERD\u4ee3\u8868\u4e73\u764c\u5167\u5206\u6ccc\u6cbb\u7642\u7684\u6b21\u4e16\u4ee3\u7a81\u7834,\u6709\u671b\u53d6\u4ee3\u73fe\u6709\u6ce8\u5c04\u5291\u578b\u4e26\u64f4\u5927\u6cbb\u7642\u4eba\u7fa4,\u5c0d\u5168\u7403\u4e73\u764c\u6cbb\u7642\u6a19\u6e96\u5177\u91cd\u5927\u5f71\u97ff\u3002Roche\u9ad8\u5c64\u7684\u5805\u6301\u8868\u614b\u53ef\u80fd\u6697\u793a\u516c\u53f8\u638c\u63e1\u7684\u6578\u64da\u6bd4\u5916\u754c\u4e86\u89e3\u7684\u66f4\u70ba\u6a02\u89c0,\u6216\u8005\u53cd\u6620\u5176\u5c0d\u8a72\u9818\u57df\u7684\u6230\u7565\u6027\u6295\u5165\u6c7a\u5fc3\u3002\u9019\u9805\u7522\u54c1\u7684\u6210\u6557\u5c07\u76f4\u63a5\u5f71\u97ffRoche\u5728\u816b\u7624\u5b78\u9818\u57df\u7684\u672a\u4f86\u7af6\u722d\u5730\u4f4d,\u4e5f\u6538\u95dc\u5168\u7403\u4e73\u764c\u60a3\u8005\u7684\u6cbb\u7642\u9078\u64c7\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u9ad8\u5c64\u6a02\u89c0\u8868\u614b\u53ef\u80fd\u662f\u70ba\u4e86\u7a69\u5b9a\u6295\u8cc7\u4eba\u4fe1\u5fc3,\u4f46\u5982\u679c\u81e8\u5e8a\u6578\u64da\u78ba\u5be6\u5b58\u5728\u7642\u6548\u6216\u5b89\u5168\u6027\u7591\u616e,\u5e02\u5834\u63a5\u53d7\u5ea6\u6050\u6015\u6703\u5927\u5e45\u4f4e\u65bc\u9810\u671f,\u4e14\u7af6\u722d\u5c0d\u624b\u53ef\u80fd\u6436\u5148\u63a8\u51fa\u66f4\u512a\u79c0\u7684\u53e3\u670dSERD\u7522\u54c1\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>\u8a73\u7d30\u81e8\u5e8a\u8a66\u9a57\u6578\u64da\u7684\u5b8c\u6574\u516c\u5e03\u6642\u7a0b<\/li><li>FDA\u8207\u6b50\u76df\u85e5\u76e3\u6a5f\u69cb\u7684\u521d\u6b65\u56de\u61c9<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>\u7af6\u722d\u5c0d\u624b\u53e3\u670dSERD\u7522\u54c1\u958b\u767c\u9032\u5ea6<\/li><li>\u91ab\u5e2b\u8207\u60a3\u8005\u5c0d\u65b0\u6578\u64da\u7684\u63a5\u53d7\u7a0b\u5ea6<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>\u53e3\u670dSERD\u7d0d\u5165\u6cbb\u7642\u6307\u5f15\u7684\u6642\u9593<\/li><li>\u5c0d\u65e2\u6709\u5167\u5206\u6ccc\u6cbb\u7642\u5e02\u5834\u7684\u66ff\u4ee3\u7a0b\u5ea6<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>\u4ec0\u9ebc\u662f\u53e3\u670dSERD,\u70ba\u4ec0\u9ebc\u9019\u9ebc\u91cd\u8981?<\/summary><p>\u53e3\u670dSERD\u662f\u65b0\u4e00\u4ee3\u4e73\u764c\u5167\u5206\u6ccc\u6cbb\u7642\u85e5\u7269,\u76f8\u6bd4\u73fe\u6709\u6ce8\u5c04\u5291\u578b\u66f4\u4fbf\u5229,\u4e14\u80fd\u66f4\u6709\u6548\u963b\u65b7\u96cc\u6fc0\u7d20\u53d7\u9ad4,\u5c0d\u6297\u8377\u723e\u8499\u53d7\u9ad4\u967d\u6027\u4e73\u764c\u6548\u679c\u66f4\u4f73\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>Roche\u70ba\u4ec0\u9ebc\u5c0d\u6709\u6578\u64da\u7591\u616e\u7684\u7522\u54c1\u9019\u9ebc\u6709\u4fe1\u5fc3?<\/summary><p>\u53ef\u80fd\u662f\u516c\u53f8\u638c\u63e1\u7684\u5b8c\u6574\u6578\u64da\u6bd4\u5916\u754c\u5df2\u77e5\u7684\u66f4\u6b63\u9762,\u6216\u8005\u8a8d\u70ba\u5373\u4f7f\u7642\u6548\u7565\u4f4e\u65bc\u9810\u671f,\u53e3\u670d\u4fbf\u5229\u6027\u4ecd\u80fd\u5275\u9020\u9f90\u5927\u5546\u696d\u50f9\u503c\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u9019\u9805\u7522\u54c1\u5982\u679c\u6210\u529f\u6703\u5c0d\u53f0\u7063\u751f\u91ab\u7522\u696d\u6709\u4ec0\u9ebc\u5f71\u97ff?<\/summary><p>\u53ef\u80fd\u5e36\u52d5\u53f0\u7063CDMO\u696d\u8005\u627f\u63a5\u76f8\u95dc\u4ee3\u5de5\u8a02\u55ae,\u540c\u6642\u523a\u6fc0\u672c\u571f\u65b0\u85e5\u516c\u53f8\u52a0\u901f\u958b\u767c\u985e\u4f3c\u7684\u53e3\u670d\u5167\u5206\u6ccc\u6cbb\u7642\u85e5\u7269\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/pharma\/roche-pharma-ceo-maintains-oral-serd-could-be-largest-product-company-history-despite-data\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<article class=\"c\" itemscope=\"\" itemtype=\"https:\/\/schema.org\/NewsArticle\">\n<header class=\"c-hd\">\n<span class=\"c-cat\" style=\"--cc:#70AD47\">\u65b0\u8208\u7642\u6cd5<\/span>\n<span class=\"c-snt s-up\">\u25b2 \u504f\u591a<\/span>\n<\/header>\n<h3 class=\"c-t\" itemprop=\"headline\"><a href=\"https:\/\/www.fiercebiotech.com\/pharma\/regeneron-ushers-new-genetic-medicine-era-groundbreaking-gene-therapy-approval\" rel=\"noopener nofollow\" target=\"_blank\">Regeneron\u4ee5\u7a81\u7834\u6027\u57fa\u56e0\u7642\u6cd5\u7372\u6279\u63ed\u958b\u907a\u50b3\u91ab\u5b78\u65b0\u6642\u4ee3<\/a><\/h3>\n<div class=\"c-src\">\u4f86\u6e90\uff1a<span itemprop=\"publisher\">FierceBiotech<\/span> \u00b7 <time datetime=\"2026-04-24\" itemprop=\"datePublished\">2026-04-24<\/time><\/div>\n<div class=\"c-hype\"><span class=\"c-hype-lb\">\u7522\u696d\u91cd\u8981\u6027<\/span><span class=\"c-hype-dots\">\u25cf\u25cf\u25cf\u25cf\u25cb<\/span><span class=\"c-hype-tx\">4\/5 \u00b7 \u91cd\u5927\u8a0a\u865f<\/span><\/div>\n<div class=\"c-stocks\"><span class=\"stk stk-us\"><b>REGN<\/b> Regeneron <span class=\"chg chg-up\">\u25b22.60% $766.02<\/span><\/span><span class=\"stk stk-us\"><b>GILD<\/b> Gilead Sciences <span class=\"chg chg-up\">\u25b20.56% $133.64<\/span><\/span><span class=\"stk stk-us\"><b>BMRN<\/b> BioMarin <span class=\"chg chg-down\">\u25bc0.31% $53.98<\/span><\/span><span class=\"stk stk-us\"><b>NVS<\/b> Novartis <span class=\"chg chg-up\">\u25b20.11% $147.48<\/span><\/span><span class=\"stk stk-tw\"><b>3176<\/b> \u57fa\u4e9e\u751f\u6280 <span class=\"chg chg-flat\">\u2014<\/span><\/span><\/div>\n<section class=\"c-analysis\" itemprop=\"articleBody\">\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u4e8b\u4ef6<\/h4>\n<p>Regeneron\u7372\u5f97\u4e00\u9805\u7a81\u7834\u6027\u57fa\u56e0\u7642\u6cd5\u7684\u76e3\u7ba1\u6279\u51c6,\u6a19\u8a8c\u8457\u8a72\u516c\u53f8\u6b63\u5f0f\u9032\u5165\u57fa\u56e0\u6cbb\u7642\u9818\u57df,\u4e26\u53ef\u80fd\u70ba\u7f55\u898b\u907a\u50b3\u75be\u75c5\u6cbb\u7642\u958b\u95e2\u65b0\u7684\u6cbb\u7642\u6a19\u6e96\u3002\u9019\u9805\u6279\u51c6\u4ee3\u8868Regeneron\u5f9e\u50b3\u7d71\u6297\u9ad4\u85e5\u7269\u5e73\u53f0\u6210\u529f\u64f4\u5c55\u81f3\u57fa\u56e0\u91ab\u5b78\u9818\u57df,\u5177\u6709\u91cd\u8981\u6230\u7565\u610f\u7fa9\u3002<\/p>\n<\/div>\n<div class=\"c-sec\">\n<h4>\u95dc\u9375\u6578\u64da<\/h4>\n<p>\u5168\u7403\u57fa\u56e0\u6cbb\u7642\u5e02\u5834\u9810\u4f302030\u5e74\u5c07\u9054440\u5104\u7f8e\u5143,\u5e74\u8907\u5408\u6210\u9577\u7387\u7d0425%\u3002\u76ee\u524d\u5df2\u6709\u8d85\u904e30\u9805\u57fa\u56e0\u7642\u6cd5\u7372FDA\u6279\u51c6,\u55ae\u6b21\u6cbb\u7642\u8cbb\u7528\u901a\u5e38\u4ecb\u65bc50\u842c\u81f3300\u842c\u7f8e\u5143\u3002Regeneron\u5728\u57fa\u56e0\u6cbb\u7642\u7684\u6295\u8cc7\u7d2f\u8a08\u8d85\u904e20\u5104\u7f8e\u5143\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide\">\n<h4>\u5e02\u5834\u91cd\u8981\u6027<\/h4>\n<p>Regeneron\u9032\u5165\u57fa\u56e0\u6cbb\u7642\u9818\u57df\u5c07\u52a0\u5287\u9019\u500b\u9ad8\u50f9\u503c\u5e02\u5834\u7684\u7af6\u722d,\u540c\u6642\u9a57\u8b49\u4e86\u5927\u578b\u85e5\u5ee0\u5f9e\u50b3\u7d71\u85e5\u7269\u5e73\u53f0\u8f49\u5411\u7cbe\u6e96\u57fa\u56e0\u91ab\u5b78\u7684\u53ef\u884c\u6027\u3002\u6b64\u6279\u51c6\u4e0d\u50c5\u70ba\u7f55\u898b\u75be\u75c5\u60a3\u8005\u5e36\u4f86\u65b0\u5e0c\u671b,\u66f4\u53ef\u80fd\u50ac\u5316\u6574\u500b\u57fa\u56e0\u6cbb\u7642\u7522\u696d\u93c8\u7684\u6280\u8853\u5275\u65b0\u8207\u6295\u8cc7\u71b1\u6f6e\u3002\u5c0d\u5168\u7403\u57fa\u56e0\u6cbb\u7642\u751f\u614b\u7cfb\u7d71\u800c\u8a00,\u9019\u610f\u5473\u8457\u8f09\u9ad4\u6280\u8853\u3001\u57fa\u56e0\u7de8\u8f2f\u5de5\u5177\u3001\u4ee5\u53ca\u5c08\u696d\u5316\u88fd\u9020\u7522\u80fd\u7684\u9700\u6c42\u5c07\u6301\u7e8c\u6500\u5347\u3002<\/p>\n<\/div>\n<div class=\"c-sec c-wide c-counter\">\n<h4>\u26a0 \u53cd\u9762\u89c0\u9ede<\/h4>\n<blockquote>\u57fa\u56e0\u6cbb\u7642\u96d6\u6709\u7a81\u7834\u4f46\u4ecd\u9762\u81e8\u88fd\u9020\u6210\u672c\u9ad8\u6602\u3001\u9577\u671f\u5b89\u5168\u6027\u672a\u660e\u3001\u4ee5\u53ca\u7d66\u4ed8\u5236\u5ea6\u4e0d\u5b8c\u5584\u7b49\u6311\u6230,\u55ae\u4e00\u7522\u54c1\u6210\u529f\u4e0d\u4ee3\u8868\u6574\u9ad4\u5546\u696d\u6a21\u5f0f\u5df2\u8da8\u6210\u719f\u3002<\/blockquote>\n<\/div>\n<div class=\"c-sec c-wide c-watch\">\n<h4>\ud83d\udccd \u63a5\u4e0b\u4f86\u89c0\u5bdf<\/h4>\n<div class=\"c-watch-grid\">\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-short\">\ud83d\udd25 \u77ed\u671f\u50ac\u5316\u5291<span>1-3 \u500b\u6708<\/span><\/div><ul><li>\u5177\u9ad4\u9069\u61c9\u75c7\u8207\u5b9a\u50f9\u7b56\u7565\u516c\u5e03<\/li><li>\u5176\u4ed6\u76e3\u7ba1\u6a5f\u69cb\u6279\u51c6\u6642\u7a0b<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-mid\">\ud83d\udc41 \u4e2d\u671f\u89c0\u5bdf<span>3-12 \u500b\u6708<\/span><\/div><ul><li>\u5be6\u969b\u5e02\u5834\u63a5\u53d7\u5ea6\u8207\u92b7\u552e\u8868\u73fe<\/li><li>\u7af6\u722d\u5c0d\u624b\u57fa\u56e0\u7642\u6cd5\u7ba1\u7dda\u52a0\u901f\u63a8\u9032<\/li><\/ul><\/div>\n<div class=\"c-watch-col\"><div class=\"c-watch-h c-w-long\">\ud83c\udfaf \u9577\u671f\u8b8a\u6578<span>1 \u5e74\u4ee5\u4e0a<\/span><\/div><ul><li>\u57fa\u56e0\u6cbb\u7642\u88fd\u9020\u6210\u672c\u4e0b\u964d\u8da8\u52e2<\/li><li>\u6b21\u4e16\u4ee3\u57fa\u56e0\u7de8\u8f2f\u6280\u8853\u6574\u5408\u61c9\u7528<\/li><\/ul><\/div>\n<\/div>\n<\/div>\n<div class=\"c-sec c-wide c-faqs\">\n<h4>\u2753 \u5e38\u898b\u554f\u984c<\/h4>\n<details class=\"c-faq-item\"><summary>Regeneron\u9019\u9805\u57fa\u56e0\u6cbb\u7642\u91dd\u5c0d\u4ec0\u9ebc\u75be\u75c5?<\/summary><p>\u96d6\u7136\u5177\u9ad4\u75be\u75c5\u672a\u5728\u6a19\u984c\u4e2d\u660e\u793a,\u4f46Regeneron\u8fd1\u671f\u805a\u7126\u65bc\u773c\u79d1\u907a\u50b3\u75be\u75c5\u3001\u795e\u7d93\u9000\u5316\u75be\u75c5\u7b49\u7f55\u898b\u907a\u50b3\u6027\u75be\u75c5\u7684\u57fa\u56e0\u6cbb\u7642\u958b\u767c\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u57fa\u56e0\u6cbb\u7642\u70ba\u4ec0\u9ebc\u9019\u9ebc\u6602\u8cb4?<\/summary><p>\u4e3b\u8981\u56e0\u70ba\u7814\u767c\u6210\u672c\u9f90\u5927\u3001\u60a3\u8005\u4eba\u6578\u7a00\u5c11\u3001\u88fd\u9020\u6280\u8853\u8907\u96dc,\u4e14\u901a\u5e38\u662f\u4e00\u6b21\u6027\u6cbb\u7642,\u9700\u8981\u5c07\u6574\u500b\u6cbb\u7642\u50f9\u503c\u6fc3\u7e2e\u5728\u55ae\u6b21\u7d66\u85e5\u4e2d\u3002<\/p><\/details><details class=\"c-faq-item\"><summary>\u53f0\u7063\u5728\u57fa\u56e0\u6cbb\u7642\u9818\u57df\u6709\u4ec0\u9ebc\u6a5f\u6703?<\/summary><p>\u53f0\u7063\u5728\u8f09\u9ad4\u88fd\u9020\u3001\u57fa\u56e0\u7de8\u8f2f\u5de5\u5177\u958b\u767c\u3001\u4ee5\u53ca\u4e9e\u6d32\u7279\u6709\u907a\u50b3\u75be\u75c5\u7814\u7a76\u65b9\u9762\u5177\u6709\u512a\u52e2,\u53ef\u900f\u904e\u570b\u969b\u5408\u4f5c\u53c3\u8207\u5168\u7403\u57fa\u56e0\u6cbb\u7642\u4f9b\u61c9\u93c8\u3002<\/p><\/details>\n<\/div>\n<\/section>\n<footer class=\"c-ft\"><a href=\"https:\/\/www.fiercebiotech.com\/pharma\/regeneron-ushers-new-genetic-medicine-era-groundbreaking-gene-therapy-approval\" rel=\"noopener nofollow\" target=\"_blank\">\u95b1\u8b80\u539f\u6587 \u2192<\/a><\/footer>\n<\/article>\n<\/section>\n<section aria-labelledby=\"sec-briefs\">\n<h2 class=\"lbl\" id=\"sec-briefs\">\u4eca\u65e5\u5feb\u8a0a<\/h2>\n<ul class=\"briefs\" style=\"list-style:none\">\n<li class=\"b-item\">\n<span class=\"b-dot\" style=\"background:#4472C4\"><\/span>\n<div><a class=\"b-link\" href=\"https:\/\/www.fiercebiotech.com\/biotech\/debt-acceptable-prices-roche-ceo-lists-3-reasons-sitting-out-big-pharma-deal-spree\" rel=\"noopener nofollow\" target=\"_blank\">&lt;a href=&#8221;https:\/\/www.fiercebiotech.com\/biotech\/debt-acceptable-prices-roche-ceo-lists-3-reasons-sitting-out-big-pharma-deal-spree&#8221; hreflang=&#8221;en&#8221;&gt;From debt to &#8216;acceptable&#8217; prices: Roche CEO lists 3 reasons for sitting out Big Pharma M&amp;amp;A spree&lt;\/a&gt;<\/a>\n<span class=\"b-meta\">\u85e5\u7269 \u00b7 FierceBiotech<\/span><\/div>\n<\/li>\n<\/ul>\n<\/section>\n<section aria-labelledby=\"sec-stats\" class=\"stats\" style=\"margin-top:48px\">\n<h2 class=\"lbl\" id=\"sec-stats\" style=\"font-size:16px;border-bottom-width:1px\">\u5206\u985e\u7d71\u8a08<\/h2>\n<div class=\"st\"><div class=\"st-bar\" style=\"width:75.0%;background:#4472C4\"><\/div><span class=\"st-lb\">\u85e5\u7269<\/span><span class=\"st-ct\">3<\/span><\/div><div class=\"st\"><div class=\"st-bar\" style=\"width:25.0%;background:#70AD47\"><\/div><span class=\"st-lb\">\u65b0\u8208\u7642\u6cd5<\/span><span class=\"st-ct\">1<\/span><\/div>\n<\/section>\n<!-- footer \u5df2\u79fb\u9664(v2.14.0) -->\n<\/main>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>2026 \u5e74 04 \u6708 24 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 \u5171\u6536\u9304 4 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e \u00b7 3 \u5247\u7cbe\u9078\u6df1\u5ea6\u5206\u6790 \u7cbe\u9078 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"parent":7356,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"rank_math_title":"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-04-24\uff5cPfizer\u505c\u6b62\u5728\u764c\u75c7\u60a3\u8005\u4e2d\u7684\u6b21\u4e16\u4ee3\u85e5\u7269\u7d50\u5408\u9ad4\u5de5\u4f5c","rank_math_description":"2026 \u5e74 04 \u6708 24 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1aPfizer\u505c\u6b62\u5728\u764c\u75c7\u60a3\u8005\u4e2d\u7684\u6b21\u4e16\u4ee3\u85e5\u7269\u7d50\u5408\u9ad4\u5de5\u4f5c\u3001\u5118\u7ba1\u6578\u64da\u5b58\u7591,Roche\u9ad8\u5c64\u5805\u6301\u53e3\u670dSERD\u4ecd\u53ef\u80fd\u6210\u70ba\u516c\u53f8\u53f2\u4e0a\u6700\u5927\u7522\u54c1\u3002\u5171\u6536\u9304 4 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002","rank_math_focus_keyword":"\u751f\u91ab\u5927\u5065\u5eb7","rank_math_robots":"","daily_schema_jsonld":"[\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"CollectionPage\",\n    \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831 2026-04-24\uff5cPfizer\u505c\u6b62\u5728\u764c\u75c7\u60a3\u8005\u4e2d\u7684\u6b21\u4e16\u4ee3\u85e5\u7269\u7d50\u5408\u9ad4\u5de5\u4f5c\",\n    \"description\": \"2026 \u5e74 04 \u6708 24 \u65e5 \u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\uff1aPfizer\u505c\u6b62\u5728\u764c\u75c7\u60a3\u8005\u4e2d\u7684\u6b21\u4e16\u4ee3\u85e5\u7269\u7d50\u5408\u9ad4\u5de5\u4f5c\u3001\u5118\u7ba1\u6578\u64da\u5b58\u7591,Roche\u9ad8\u5c64\u5805\u6301\u53e3\u670dSERD\u4ecd\u53ef\u80fd\u6210\u70ba\u516c\u53f8\u53f2\u4e0a\u6700\u5927\u7522\u54c1\u3002\u5171\u6536\u9304 4 \u5247\u7522\u696d\u76f8\u95dc\u65b0\u805e,\u542b\u6df1\u5ea6\u5206\u6790\u3001\u53cd\u9762\u89c0\u9ede\u8207\u77ed\u4e2d\u9577\u671f\u89c0\u5bdf\u91cd\u9ede\u3002\",\n    \"url\": \"https:\/\/witology.com.tw\/daily\/2026-04-24\",\n    \"datePublished\": \"2026-04-24\",\n    \"inLanguage\": \"zh-TW\",\n    \"publisher\": {\n      \"@type\": \"Organization\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n      }\n    },\n    \"isPartOf\": {\n      \"@type\": \"WebSite\",\n      \"name\": \"\u667a\u749e\u79d1\u6280\",\n      \"url\": \"https:\/\/witology.com.tw\"\n    },\n    \"hasPart\": [\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Pfizer\u505c\u6b62\u5728\u764c\u75c7\u60a3\u8005\u4e2d\u7684\u6b21\u4e16\u4ee3\u85e5\u7269\u7d50\u5408\u9ad4\u5de5\u4f5c\",\n        \"datePublished\": \"2026-04-24\",\n        \"dateModified\": \"2026-04-24\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-04-24#article-1\"\n        },\n        \"description\": \"Pfizer\u7d42\u6b62\u4e86\u4e00\u9805\u8655\u65bcPhase I\u968e\u6bb5\u7684\u514d\u75ab\u523a\u6fc0\u85e5\u7269\u7d50\u5408\u9ad4(immunostimulatory drug conjugate)\u764c\u75c7\u6cbb\u7642\u8a08\u756b\u3002\u6b64\u6c7a\u5b9a\u53cd\u6620\u8a72\u85e5\u7269\u5728\u65e9\u671f\u81e8\u5e8a\u8a66\u9a57\u4e2d\u672a\u9054\u9810\u671f\u6548\u679c\u6216\u5b89\u5168\u6027\u8003\u91cf,\u986f\u793aADC\u6280\u8853\u8def\u7dda\u4ecd\u5b58\u5728\u958b\u767c\u98a8\u96aa\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-04-24#article-1\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/biotech\/pfizer-ends-work-phase-1-stage-immunostimulatory-drug-conjugate-cancer-patients\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Pfizer\",\n            \"tickerSymbol\": \"PFE\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Roche\",\n            \"tickerSymbol\": \"RHHBY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"AstraZeneca\",\n            \"tickerSymbol\": \"AZN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Gilead Sciences\",\n            \"tickerSymbol\": \"GILD\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u85e5\u83ef\u85e5\",\n            \"tickerSymbol\": \"6446\"\n          }\n        ]\n      },\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"\u5118\u7ba1\u6578\u64da\u5b58\u7591,Roche\u9ad8\u5c64\u5805\u6301\u53e3\u670dSERD\u4ecd\u53ef\u80fd\u6210\u70ba\u516c\u53f8\u53f2\u4e0a\u6700\u5927\u7522\u54c1\",\n        \"datePublished\": \"2026-04-24\",\n        \"dateModified\": \"2026-04-24\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-04-24#article-2\"\n        },\n        \"description\": \"Roche\u9ad8\u5c64\u5728\u9762\u81e8\u53e3\u670d\u9078\u64c7\u6027\u96cc\u6fc0\u7d20\u53d7\u9ad4\u964d\u89e3\u5291(SERD)\u81e8\u5e8a\u6578\u64da\u8cea\u7591\u8072\u6d6a\u4e0b,\u4ecd\u5805\u6301\u8a8d\u70ba\u8a72\u7522\u54c1\u5177\u5099\u6210\u70ba\u516c\u53f8\u53f2\u4e0a\u6700\u5927\u7522\u54c1\u7684\u6f5b\u529b\u3002\u6b64\u8868\u614b\u986f\u793aRoche\u5c0d\u4e73\u764c\u6cbb\u7642\u5e02\u5834\u7684\u9577\u671f\u4fe1\u5fc3,\u4f46\u4e5f\u53cd\u6620\u7576\u524d\u6578\u64da\u53ef\u80fd\u672a\u5b8c\u5168\u7b26\u5408\u5e02\u5834\u9810\u671f\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-04-24#article-2\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/pharma\/roche-pharma-ceo-maintains-oral-serd-could-be-largest-product-company-history-despite-data\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Roche\",\n            \"tickerSymbol\": \"RHHBY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"AstraZeneca\",\n            \"tickerSymbol\": \"AZN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Eli Lilly\",\n            \"tickerSymbol\": \"LLY\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Pfizer\",\n            \"tickerSymbol\": \"PFE\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u4e2d\u5929\u751f\u6280\",\n            \"tickerSymbol\": \"4128\"\n          }\n        ]\n      },\n      {\n        \"@type\": \"NewsArticle\",\n        \"headline\": \"Regeneron\u4ee5\u7a81\u7834\u6027\u57fa\u56e0\u7642\u6cd5\u7372\u6279\u63ed\u958b\u907a\u50b3\u91ab\u5b78\u65b0\u6642\u4ee3\",\n        \"datePublished\": \"2026-04-24\",\n        \"dateModified\": \"2026-04-24\",\n        \"image\": [\n          \"https:\/\/witology.com.tw\/logo.png\"\n        ],\n        \"author\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\u7de8\u8f2f\u90e8\"\n        },\n        \"publisher\": {\n          \"@type\": \"Organization\",\n          \"name\": \"\u667a\u749e\u79d1\u6280\",\n          \"logo\": {\n            \"@type\": \"ImageObject\",\n            \"url\": \"https:\/\/witology.com.tw\/logo.png\"\n          }\n        },\n        \"mainEntityOfPage\": {\n          \"@type\": \"WebPage\",\n          \"@id\": \"https:\/\/witology.com.tw\/daily\/2026-04-24#article-3\"\n        },\n        \"description\": \"Regeneron\u7372\u5f97\u4e00\u9805\u7a81\u7834\u6027\u57fa\u56e0\u7642\u6cd5\u7684\u76e3\u7ba1\u6279\u51c6,\u6a19\u8a8c\u8457\u8a72\u516c\u53f8\u6b63\u5f0f\u9032\u5165\u57fa\u56e0\u6cbb\u7642\u9818\u57df,\u4e26\u53ef\u80fd\u70ba\u7f55\u898b\u907a\u50b3\u75be\u75c5\u6cbb\u7642\u958b\u95e2\u65b0\u7684\u6cbb\u7642\u6a19\u6e96\u3002\u9019\u9805\u6279\u51c6\u4ee3\u8868Regeneron\u5f9e\u50b3\u7d71\u6297\u9ad4\u85e5\u7269\u5e73\u53f0\u6210\u529f\u64f4\u5c55\u81f3\u57fa\u56e0\u91ab\u5b78\u9818\u57df,\u5177\u6709\u91cd\u8981\u6230\u7565\u610f\u7fa9\u3002\",\n        \"url\": \"https:\/\/witology.com.tw\/daily\/2026-04-24#article-3\",\n        \"isBasedOn\": \"https:\/\/www.fiercebiotech.com\/pharma\/regeneron-ushers-new-genetic-medicine-era-groundbreaking-gene-therapy-approval\",\n        \"about\": [\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Regeneron\",\n            \"tickerSymbol\": \"REGN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Gilead Sciences\",\n            \"tickerSymbol\": \"GILD\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"BioMarin\",\n            \"tickerSymbol\": \"BMRN\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"Novartis\",\n            \"tickerSymbol\": \"NVS\"\n          },\n          {\n            \"@type\": \"Corporation\",\n            \"name\": \"\u57fa\u4e9e\u751f\u6280\",\n            \"tickerSymbol\": \"3176\"\n          }\n        ]\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"BreadcrumbList\",\n    \"itemListElement\": [\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 1,\n        \"name\": \"\u9996\u9801\",\n        \"item\": \"https:\/\/witology.com.tw\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 2,\n        \"name\": \"\u751f\u91ab\u5927\u5065\u5eb7\u7522\u696d\u65e5\u5831\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\"\n      },\n      {\n        \"@type\": \"ListItem\",\n        \"position\": 3,\n        \"name\": \"2026-04-24\",\n        \"item\": \"https:\/\/witology.com.tw\/daily\/2026-04-24\"\n      }\n    ]\n  },\n  {\n    \"@context\": \"https:\/\/schema.org\",\n    \"@type\": \"FAQPage\",\n    \"mainEntity\": [\n      {\n        \"@type\": \"Question\",\n        \"name\": \"Pfizer\u505c\u6b62\u9019\u9805\u764c\u75c7\u85e5\u7269\u958b\u767c\u5c0d\u516c\u53f8\u5f71\u97ff\u591a\u5927?\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u5f71\u97ff\u76f8\u5c0d\u6709\u9650,\u56e0\u70baPfizer\u900f\u904e\u6536\u8cfcSeagen\u5df2\u64c1\u6709\u591a\u9805ADC\u7ba1\u7dda,\u55ae\u4e00\u9805\u76ee\u505c\u6b62\u5c6c\u65bc\u6b63\u5e38\u7684\u7814\u767c\u98a8\u96aa\u7ba1\u63a7\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u4ec0\u9ebc\u662f\u514d\u75ab\u523a\u6fc0\u85e5\u7269\u7d50\u5408\u9ad4?\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u9019\u662f\u7d50\u5408\u6297\u9ad4\u5c0e\u5411\u6027\u8207\u514d\u75ab\u523a\u6fc0\u5291\u7684\u65b0\u578bADC\u6280\u8853,\u65e8\u5728\u7cbe\u6e96\u6295\u905e\u514d\u75ab\u6fc0\u6d3b\u5206\u5b50\u5230\u816b\u7624\u7d30\u80de,\u4f46\u6280\u8853\u8907\u96dc\u5ea6\u6bd4\u50b3\u7d71ADC\u66f4\u9ad8\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"ADC\u85e5\u7269\u958b\u767c\u70ba\u4ec0\u9ebc\u9019\u9ebc\u56f0\u96e3?\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"ADC\u9700\u8981\u540c\u6642\u512a\u5316\u6297\u9ad4\u9078\u64c7\u6027\u3001\u9023\u63a5\u5b50\u7a69\u5b9a\u6027\u3001\u6709\u6548\u8f09\u8377\u6bd2\u6027\u7b49\u591a\u500b\u8b8a\u6578,\u4efb\u4e00\u74b0\u7bc0\u5931\u8861\u90fd\u53ef\u80fd\u5c0e\u81f4\u7642\u6548\u4e0d\u8db3\u6216\u6bd2\u6027\u904e\u9ad8\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u4ec0\u9ebc\u662f\u53e3\u670dSERD,\u70ba\u4ec0\u9ebc\u9019\u9ebc\u91cd\u8981?\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53e3\u670dSERD\u662f\u65b0\u4e00\u4ee3\u4e73\u764c\u5167\u5206\u6ccc\u6cbb\u7642\u85e5\u7269,\u76f8\u6bd4\u73fe\u6709\u6ce8\u5c04\u5291\u578b\u66f4\u4fbf\u5229,\u4e14\u80fd\u66f4\u6709\u6548\u963b\u65b7\u96cc\u6fc0\u7d20\u53d7\u9ad4,\u5c0d\u6297\u8377\u723e\u8499\u53d7\u9ad4\u967d\u6027\u4e73\u764c\u6548\u679c\u66f4\u4f73\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"Roche\u70ba\u4ec0\u9ebc\u5c0d\u6709\u6578\u64da\u7591\u616e\u7684\u7522\u54c1\u9019\u9ebc\u6709\u4fe1\u5fc3?\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53ef\u80fd\u662f\u516c\u53f8\u638c\u63e1\u7684\u5b8c\u6574\u6578\u64da\u6bd4\u5916\u754c\u5df2\u77e5\u7684\u66f4\u6b63\u9762,\u6216\u8005\u8a8d\u70ba\u5373\u4f7f\u7642\u6548\u7565\u4f4e\u65bc\u9810\u671f,\u53e3\u670d\u4fbf\u5229\u6027\u4ecd\u80fd\u5275\u9020\u9f90\u5927\u5546\u696d\u50f9\u503c\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u9019\u9805\u7522\u54c1\u5982\u679c\u6210\u529f\u6703\u5c0d\u53f0\u7063\u751f\u91ab\u7522\u696d\u6709\u4ec0\u9ebc\u5f71\u97ff?\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53ef\u80fd\u5e36\u52d5\u53f0\u7063CDMO\u696d\u8005\u627f\u63a5\u76f8\u95dc\u4ee3\u5de5\u8a02\u55ae,\u540c\u6642\u523a\u6fc0\u672c\u571f\u65b0\u85e5\u516c\u53f8\u52a0\u901f\u958b\u767c\u985e\u4f3c\u7684\u53e3\u670d\u5167\u5206\u6ccc\u6cbb\u7642\u85e5\u7269\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"Regeneron\u9019\u9805\u57fa\u56e0\u6cbb\u7642\u91dd\u5c0d\u4ec0\u9ebc\u75be\u75c5?\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u96d6\u7136\u5177\u9ad4\u75be\u75c5\u672a\u5728\u6a19\u984c\u4e2d\u660e\u793a,\u4f46Regeneron\u8fd1\u671f\u805a\u7126\u65bc\u773c\u79d1\u907a\u50b3\u75be\u75c5\u3001\u795e\u7d93\u9000\u5316\u75be\u75c5\u7b49\u7f55\u898b\u907a\u50b3\u6027\u75be\u75c5\u7684\u57fa\u56e0\u6cbb\u7642\u958b\u767c\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u57fa\u56e0\u6cbb\u7642\u70ba\u4ec0\u9ebc\u9019\u9ebc\u6602\u8cb4?\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u4e3b\u8981\u56e0\u70ba\u7814\u767c\u6210\u672c\u9f90\u5927\u3001\u60a3\u8005\u4eba\u6578\u7a00\u5c11\u3001\u88fd\u9020\u6280\u8853\u8907\u96dc,\u4e14\u901a\u5e38\u662f\u4e00\u6b21\u6027\u6cbb\u7642,\u9700\u8981\u5c07\u6574\u500b\u6cbb\u7642\u50f9\u503c\u6fc3\u7e2e\u5728\u55ae\u6b21\u7d66\u85e5\u4e2d\u3002\"\n        }\n      },\n      {\n        \"@type\": \"Question\",\n        \"name\": \"\u53f0\u7063\u5728\u57fa\u56e0\u6cbb\u7642\u9818\u57df\u6709\u4ec0\u9ebc\u6a5f\u6703?\",\n        \"acceptedAnswer\": {\n          \"@type\": \"Answer\",\n          \"text\": \"\u53f0\u7063\u5728\u8f09\u9ad4\u88fd\u9020\u3001\u57fa\u56e0\u7de8\u8f2f\u5de5\u5177\u958b\u767c\u3001\u4ee5\u53ca\u4e9e\u6d32\u7279\u6709\u907a\u50b3\u75be\u75c5\u7814\u7a76\u65b9\u9762\u5177\u6709\u512a\u52e2,\u53ef\u900f\u904e\u570b\u969b\u5408\u4f5c\u53c3\u8207\u5168\u7403\u57fa\u56e0\u6cbb\u7642\u4f9b\u61c9\u93c8\u3002\"\n        }\n      }\n    ]\n  }\n]","daily_standalone_url":"","footnotes":""},"class_list":["post-7394","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/comments?post=7394"}],"version-history":[{"count":0,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7394\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/pages\/7356"}],"wp:attachment":[{"href":"https:\/\/witology.com.tw\/en\/wp-json\/wp\/v2\/media?parent=7394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}